HEALTHJun 9 · 13:34 UTCSTAT NEWSMario Aguilar

Dexcom RCT suggests CGM benefits for broad diabetes population

A Dexcom randomized controlled trial (RCT) indicates that continuous glucose monitoring (CGM) offers benefits for a broad population of diabetes patients. The study's findings suggest CGM could be advantageous beyond specific subgroups.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Dexcomorganizationcontinuous glucose monitoringtopicdiabetestopicrandomized controlled trialtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 7 · 10:11 UTC
Scientists discover why Ozempic works better for some people
HEALTHMay 15 · 15:01 UTC
Dexcom’s Bet Beyond Diabetes
HEALTHMay 19 · 07:02 UTC
Scientists found a smarter Mediterranean diet that slashes diabetes risk by 31%
HEALTHApr 30 · 19:14 UTC
Vitamin supplement may delay diabetes in select groups, researchers say
HEALTHMay 7 · 15:32 UTC
Diabetes Detection Needs Better Tools. They’re on the Way
HEALTHApr 21 · 14:22 UTC
Eating a high-fat, low-carb diet could 'benefit people with type 2 diabetes', study suggests: 'Reduces strain on the pancreas'